19 research outputs found
Temporal Changes in Air Quality during a Festival Season in Kannur, India
This study looked at the variation in air quality during the periods of fireworks as assessed from the change in ambient concentrations of air pollutants like particulate matter (PM10), O3, and NO2 for pre-, post-, and Vishu days for four consecutive years in 2015, 2016, 2017, and 2018 in Kannur, India. Enhanced levels of O3, NO2, NO, and PM10 were observed during the intense usage of fireworks. The concentration of metals in PM10 increased and the percent increase was found to be different for metal traces. A pronounced increase in the aerosol optical depth (AOD) in the lower wavelength region of solar radiation reveals the abundance of fine mode particles. The concentrations of O3 and NO2 were observed to increase by more than 100% on Vishu day than the control days for the observational period. Simulation using the National Center for Atmospheric Research (NCAR) Master Mechanism photochemical box model indicates a more than 100% enhancement in NO2 photolysis rates during the fireworks episode, which leads to a 100% increase in the surface ozone production. Observations as well as model simulations indicate that the enhanced photochemical ozone production from NO2 photolysis is possibly the main driver of ozone production during the Vishu at this site. The air quality index (AQI) revealed the deterioration of air quality at the observational site during the period of Vishu
IgA Plasma Cell Leukemia
Plasma cell leukemia (PCL) is a rare entity. There are two presentations of PCL, primary or secondary. The primary or de novo form of PCL presents with an acute and rapidly progressive leukemic phase. This form occurs when the patient has no pre-existing multiple myeloma (MM). The secondary form is the most advanced form of MM. The PCL is a rare disorder representing 1–2% of the diagnosed cases of MM. Median age at presentation is usually above 50 years. The monoclonal protein in patients with PCL may be IgG (50%), IgA (15%), or in rare cases IgD or IgE (6%). We report a case of IgA primary PCL that is very rare. Patient was started on combination therapy with vincristine, adriamycin, and dexamethasone. There was poor response and patient died three months after diagnosis
Primary bone lymphoma: A report of two cases and review of the literature
Primary bone lymphoma (PBL) is an uncommon tumor accounting for
approximately 4-5% of extra nodal lymphoma and less than 1% of all
non-Hodgkin′s lymphoma. Disease may be complicated at
presentation by pathological fracture or spinal cord compression.
Diffuse large-B-cell lymphoma (DLBCL) accounts for the majority of
cases of PBL. Owing to its rarity, only a few retrospective studies
have been published addressing the prognosis and treatment of primary
bone lymphoma. In this paper, we report our experience with two cases
of PBL treated with chemotherapy and radiotherapy and review literature
to elucidate the optimal treatment of primary bone lymphoma
Prevalence of KRAS mutations in metastatic colorectal cancer: A retrospective observational study from India
Epidermal growth factor receptor mutation in non-small-cell lung carcinomas: A retrospective analysis of 1036 lung cancer specimens from a network of tertiary cancer care centers in India
Single Nucleotide Polymorphisms of Human STING Can Affect Innate Immune Response to Cyclic Dinucleotides
The STING (stimulator of interferon genes) protein can bind cyclic dinucleotides to activate the production of type I interferons and inflammatory cytokines. The cyclic dinucleotides can be bacterial second messengers c-di-GMP and c-di-AMP, 3’5’-3’5’ cyclic GMP-AMP (3’3’ cGAMP) produced by Vibrio cholerae and metazoan second messenger 2’5’-3’5’ Cyclic GMP-AMP (2’3’ cGAMP). Analysis of single nucleotide polymorphism (SNP) data from the 1000 Genome Project revealed that R71H-G230A-R293Q (HAQ) occurs in 20.4%, R232H in 13.7%, G230A-R293Q (AQ) in 5.2%, and R293Q in 1.5% of human population. In the absence of exogenous ligands, the R232H, R293Q and AQ SNPs had only modest effect on the stimulation of IFN-β and NF-κB promoter activities in HEK293T cells, while HAQ had significantly lower intrinsic activity. The decrease was primarily due to the R71H substitution. The SNPs also affected the response to the cyclic dinucleotides. In the presence of c-di-GMP, the R232H variant partially decreased the ability to activate IFN-βsignaling, while it was defective for the response to c-di-AMP and 3’3’ cGAMP. The R293Q dramatically decreased the stimulatory response to all bacterial ligands. Surprisingly, the AQ and HAQ variants maintained partial abilities to activate the IFN-β signaling in the presence of ligands due primarily to the G230A substitution. Biochemical analysis revealed that the recombinant G230A protein could affect the conformation of the C-terminal domain of STING and the binding to c-di-GMP. Comparison of G230A structure with that of WT revealed that the conformation of the lid region that clamps onto the c-di-GMP was significantly altered. These results suggest that hSTING variation can affect innate immune signaling and that the common HAQ haplotype expresses a STING protein with reduced intrinsic signaling activity but retained the ability to response to bacterial cyclic dinucleotides